Literature DB >> 33118118

Multicenter prospective trial of total gastrectomy versus proximal gastrectomy for upper third cT1 gastric cancer.

Makoto Yamasaki1, S Takiguchi2, T Omori3, M Hirao4, H Imamura5, K Fujitani6, S Tamura7, Y Akamaru8, K Kishi9, J Fujita10, T Hirao11, K Demura11, J Matsuyama12, A Takeno13, C Ebisui14, K Takachi15, O Takayama16, H Fukunaga17, K Okada18, S Adachi19, S Fukuda20, N Matsuura21, T Saito21, T Takahashi21, Y Kurokawa21, M Yano14, H Eguchi21, Y Doki21.   

Abstract

BACKGROUND: The appropriate surgical procedure for patients with upper third early gastric cancer is controversial. We compared total gastrectomy (TG) with proximal gastrectomy (PG) in this patient population.
METHODS: A multicenter, non-randomized trial was conducted, with patients treated with PG or TG. We compared short- and long-term outcomes between these procedures.
RESULTS: Between 2009 and 2014, we enrolled 254 patients from 22 institutions; data from 252 were included in the analysis. These 252 patients were assigned to either the PG (n = 159) or TG (n = 93) group. Percentage of body weight loss (%BWL) at 1 year after surgery, i.e., the primary endpoint, in the PG group was significantly less than that of the TG group (- 12.8% versus - 16.9%; p = 0.0001). For short-term outcomes, operation time was significantly shorter for PG than TG (252 min versus 303 min; p < 0.0001), but there were no group-dependent differences in blood loss and postoperative complications. For long-term outcomes, incidence of reflux esophagitis in the PG group was significantly higher than that of the TG group (14.5% versus 5.4%; p = 0.02), while there were no differences in the incidence of anastomotic stenosis between the two (5.7% versus 5.4%; p = 0.92). Overall patient survival rates were similar between the two groups (3-year survival rates: 96% versus 92% in the PG and TG groups, respectively; p = 0.49).
CONCLUSIONS: Patients who underwent PG were better able to control weight loss without worsening the prognosis, relative to those in the TG group. Optimization of a reconstruction method to reduce reflux in PG patients will be important.

Entities:  

Keywords:  Proximal gastrectomy; Total gastrectomy; Upper third gastric cancer

Mesh:

Year:  2020        PMID: 33118118     DOI: 10.1007/s10120-020-01129-6

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  3 in total

1.  Clinical outcome of proximal gastrectomy in patients with early gastric cancer in the upper third of the stomach.

Authors:  Yasumasa Kondoh; Yuichi Okamoto; Mari Morita; Kazuhito Nabeshima; Kenji Nakamura; Jinichi Soeda; Kyoji Ogoshi; Hiroyasu Makuuchi
Journal:  Tokai J Exp Clin Med       Date:  2007-07-20

2.  Clinical significance of total gastrectomy for proximal gastric cancer.

Authors:  Akira Ooki; Keishi Yamashita; Shiro Kikuchi; Shinichi Sakuramoto; Natsuya Katada; Nobue Hutawatari; Masahiko Watanabe
Journal:  Anticancer Res       Date:  2008 Sep-Oct       Impact factor: 2.480

3.  Trends in incidence of oesophageal and stomach cancer subtypes in Europe.

Authors:  Jessie Steevens; Anita A M Botterweck; Miranda J M Dirx; Piet A van den Brandt; Leo J Schouten
Journal:  Eur J Gastroenterol Hepatol       Date:  2010-06       Impact factor: 2.566

  3 in total
  3 in total

1.  Prognostic factors for cytology-positive gastric cancer: a multicenter retrospective analysis.

Authors:  Shunji Endo; Kazuhiro Nishikawa; Masakazu Ikenaga; Kazumasa Fujitani; Junji Kawada; Tomoki Yamatsuji; Hisako Kubota; Masaharu Higashida; Yoshinori Fujiwara; Tomio Ueno
Journal:  Int J Clin Oncol       Date:  2021-02-17       Impact factor: 3.402

Review 2.  Is single tract jejunal interposition better than double tract reconstruction after proximal gastrectomy?

Authors:  Shuaibing Lu; Fei Ma; Wei Yang; Liangqun Peng; Yawei Hua
Journal:  Updates Surg       Date:  2022-10-08

3.  Intracorporeal hand-sewn anastomosis following pylorus-preserving gastrectomy: surgical technique and short-term surgical outcome.

Authors:  Masaki Aizawa; Hiroshi Yabusaki; Atsushi Matsuki; Takeo Bamba; Satoru Nakagawa
Journal:  Langenbecks Arch Surg       Date:  2022-06-07       Impact factor: 2.895

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.